Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

Background Although the economic burden of multiple sclerosis (MS) in high-income
countries (HICs) has been extensively studied, information on the costs of MS in low-and …

Costs of disorders of the brain in Europe EUROPEAN JOURNAL OF NEUROLOGY Volume 12,
Supplement 1, June 2005 Costs of Disorders of the Brain in Europe Guest Editors: Patrik …

Multiple sclerosis (MS) has serious negative effects on health-, social-, and work-related
issues for the patients and their families, thus causing significant socioeconomic burden …

BACKGROUND: Before the introduction of the immunomodulatory therapies for multiple
sclerosis (MS), treatment options for MS consisted of symptomatic management (physical …

This cost-of-illness analysis for the United Kingdom is part of a Europe-wide study on the
costs of multiple sclerosis (MS). The objective was to analyze the costs and quality of life …

Introduction In light of the increasing number of economic burden studies and heterogeneity
in methodology and reporting standards, there is a need for robust evidence synthesis on an …

The present study aims at estimating the total cost of MS in Europe based on actual cost
data from nine countries and published epidemiological evidence. The epidemiological data …

This cost-of-illness analysis based on information from 921 patients in Italy is part of a
Europe-wide cost-of-illness study in multiple sclerosis (MS). The objective was to analyze …

Multiple sclerosis (MS) is a chronic progressive potentially disabling disorder with a
considerable social impact and economic consequences despite its relatively limited …